International Centre for Education and Research in Neuropsychiatry

По-русски

Our Mission

  • High Standards of Research & Education in Evidence Based Neuropsychiatry with the Trends towards Innovations and New Technologies;
  • Reunion of Basic & Clinical Neurosciences for Better Quality of Care of Psychiatric and Neurological Disorders;
  • International Collaboration Initiatives, Mentorship & Integration into Global Professional Community.

Our Goals

Goal 1. To Rely on the Efficient Team of Collaborators (Human Resource as a Priority)

Growing our Network of Collaboration Worldwide may remind us the Growing of Healthy Brain Neuronal Connections.

Goal 2. To Speak Common Language (Mutual Agreements on Research Hypotheses and Evidence Based Expertise)

Dialogue between Basic and Clinical Neurosciences leads towards Better Treatment Opportunities.

Goal 3. To Manage Meaningful Projects (Research, Development and Clinical Guidelines in Neuropsychiatry)

Team Work is focused on Research Achievements, Education of Professionals and Quality of Life of Patients.

Memorandum of Understanding between institutions(PDF, 93 KB)

Education

  • Hybrid & Bilingual Format
  • Webinars, Conferences & WEB-Library on Neuropsychiatry
  • MSc in Clinical Neurosciences

Science

  • Research Projects
  • Grants
  • Publications

Clinical Practice

  • Person-Centered Approach
  • Evidence Based Care
  • Innovative Technologies

Our research projects

  • COVID-19 associated psychiatric and neurological complications (outpatients, inpatients with severe forms in COVID-hospitals, rare clinical cases, COVID-associated olfactory disorders).
  • Mental health, Social and Psychological well-being of the population during COVID-19 pandemic, lockdowns and in the frames of social preoccupation measures (general population, students, patients with cardiovascular disorders, etc.).
  • Psycholinguistics and Neurolinguistics of socially significant mental disorders (depression, schizophrenia, dementia, etc.).
  • Thought, language and communication disorder and Social disadjustment in patients with Schizophrenia spectrum disorders (cognitive endophenotypes of schizophrenia, studies of patients and first degree relatives).
  • Motor dysfunction, Verbal fluency decline, Disrupted embodied cognition and Negative symptoms in Schizophrenia.
  • Intensive Action Language Treatment in mental and neurological disorders.
  • Machine Learning and Artificial Intelligence: Big Data of the Linguistics of Mental Disorders.
  • Evidence-based and Person-centered psychoharmacotherapy of mental disorders.
  • Virtual, Augmented Reality and Biofeedback across the evidence-based approaches to treatment and polyprofessional rehabilitation of mental and neurological disorders.
  • Hereditary Neurodegenerative diseases (Huntington’s disease, Alzheimer’s disease, Parkinson’s disease, spinocerebellar ataxias, neurodegenerative diseases with accumulation of metals in the brain, mitochondrial diseases, orphan neurological diseases).
  • Hereditary strokes, Neuromuscular diseases and Epilepsy.
  • Chronic Pain syndromes (fibromyalgia, C-fiber polyneuropathy).
  • Gluten neurological syndromes (gluten migraine, gluten fibromyalgia, gluten ataxia, gluten polyneuropathy, restless legs syndrome in celiac patients).
  • Public health, Mental health services, Psychogeriatric services.
  • Women’s Mental Health and Mental health in the Immigrant populations.
  • Hybrid education format in Neuropsychiatry: Web-Library of modern data, Novel education approaches and Academic degree Program MSc in Clinical Neurosciences.
  • International collaboration, Mentorship and Continuity of collaboration in the global professional community in Neuropsychiatry.

Methods

  • Clinical Interview.
  • Psychological Assessments.
  • Psycholinguistic method.
  • Patients’ Art.
  • Use of technologies and equipment (by contract, interlab and intrauniversity share) in the field of:
    • Brain imaging (MRI, fMRI, PET, CT etc.),
    • Neurophysiology (EEG, EMG, Eye tracking, Thermography camera, Polygraph, Neurotrend etc.),
    • Novel treatment approaches (rTMS, VR/AR, Day light therapy etc.).

Team

Memorandum of Understanding (MoU) Between Institutions

Important Collaboration

ICERN Web Library of Neuropsychiatry

Watch the playlist

Присоединяйтесь к нам в соцсетях